| First Author | Lee JH | Year | 2018 |
| Journal | Mol Cell | Volume | 70 |
| Issue | 2 | Pages | 197-210.e7 |
| PubMed ID | 29677490 | Mgi Jnum | J:265708 |
| Mgi Id | MGI:6157226 | Doi | 10.1016/j.molcel.2018.03.018 |
| Citation | Lee JH, et al. (2018) EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Mol Cell 70(2):197-210.e7 |
| abstractText | EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85alpha, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85alpha, and recruited p85alpha to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation-enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. |
